AQR Capital Management - IDENIX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
AQR Capital Management ownership history of IDENIX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2014$72,924,000
+23809.5%
3,025,872
+5891.8%
0.20%
+19600.0%
Q1 2014$305,000
-60.2%
50,500
-68.0%
0.00%
-66.7%
Q4 2012$766,000157,9340.00%
Other shareholders
IDENIX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Baupost Group 26,767,000$96,629,0002.40%
Bain Capital Public Equity Management, LLC 12,664,950$45,720,0001.07%
Camber Capital Management LP 2,750,000$9,927,0001.02%
BRIDGER MANAGEMENT, LLC 3,260,628$11,771,0000.86%
BB BIOTECH AG 1,250,000$4,513,0000.32%
GENERAL AMERICAN INVESTORS CO INC 858,979$3,101,0000.28%
Aris Wealth Services, Inc. 30,000$108,0000.23%
AlpInvest Partners B.V. 56,986$206,0000.20%
Visium Asset Management, LP 1,350,000$4,874,0000.11%
Old West Investment Management, LLC 57,949$209,0000.10%
View complete list of IDENIX PHARMACEUTICALS INC shareholders